Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Frank

Showing results (1131-1140 of 1,900) with videos related to

Pageof 190
Sort By:
Molecular Endocrinology (Baltimore, Md.)|November 1, 1996
Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinaseW Yi, S O Kim, J Jiang, et al.
Neuroscience and Biobehavioral Reviews|July 17, 2016
Motor symptoms in Parkinson's disease: A unified frameworkAhmed A Moustafa, Srinivasa Chakravarthy, Joseph R Phillips, et al.
Journal of Neuro-Oncology|January 1, 1983
Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. A Southwest Oncology Group ReportH J Eyre, J M Quagliana, J R Eltringham, et al.
Molecular Endocrinology (Baltimore, Md.)|September 4, 2004
A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysisJing Jiang, Xiangdong Wang, Kai He, et al.
Medical Physics|August 10, 2013
Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancerEnzhuo M Quan, Wei Liu, Richard Wu, et al.
The Journal of Biological Chemistry|February 3, 2016
Cholesterol Analogs with Degradation-resistant Alkyl Side Chains Are Effective Mycobacterium tuberculosis Growth InhibitorsDaniel J Frank, Yan Zhao, Siew Hoon Wong, et al.
British Journal of Clinical Pharmacology|January 1, 1986
A comparison of isoxicam pharmacokinetics in young and elderly subjectsC F George, A G Renwick, A S Darragh, et al.
Schizophrenia Bulletin|May 21, 2010
Patients with schizophrenia demonstrate inconsistent preference judgments for affective and nonaffective stimuliGregory P Strauss, Benjamin M Robinson, James A Waltz, et al.
Endocrinology|April 7, 1998
Blockade of growth hormone receptor shedding by a metalloprotease inhibitorJ Alele, J Jiang, J F Goldsmith, et al.
Psychopharmacology|October 3, 2007
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsivenessDiego A Pizzagalli, A Eden Evins, Erika Cowman Schetter, et al.
Pageof 190

Showing results (1131-1140 of 1,900) with videos related to

Sort By:
Pageof 190
Molecular Endocrinology (Baltimore, Md.)|November 1, 1996
Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinaseW Yi, S O Kim, J Jiang, et al.
Neuroscience and Biobehavioral Reviews|July 17, 2016
Motor symptoms in Parkinson's disease: A unified frameworkAhmed A Moustafa, Srinivasa Chakravarthy, Joseph R Phillips, et al.
Journal of Neuro-Oncology|January 1, 1983
Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. A Southwest Oncology Group ReportH J Eyre, J M Quagliana, J R Eltringham, et al.
Molecular Endocrinology (Baltimore, Md.)|September 4, 2004
A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysisJing Jiang, Xiangdong Wang, Kai He, et al.
Medical Physics|August 10, 2013
Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancerEnzhuo M Quan, Wei Liu, Richard Wu, et al.
The Journal of Biological Chemistry|February 3, 2016
Cholesterol Analogs with Degradation-resistant Alkyl Side Chains Are Effective Mycobacterium tuberculosis Growth InhibitorsDaniel J Frank, Yan Zhao, Siew Hoon Wong, et al.
British Journal of Clinical Pharmacology|January 1, 1986
A comparison of isoxicam pharmacokinetics in young and elderly subjectsC F George, A G Renwick, A S Darragh, et al.
Schizophrenia Bulletin|May 21, 2010
Patients with schizophrenia demonstrate inconsistent preference judgments for affective and nonaffective stimuliGregory P Strauss, Benjamin M Robinson, James A Waltz, et al.
Endocrinology|April 7, 1998
Blockade of growth hormone receptor shedding by a metalloprotease inhibitorJ Alele, J Jiang, J F Goldsmith, et al.
Psychopharmacology|October 3, 2007
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsivenessDiego A Pizzagalli, A Eden Evins, Erika Cowman Schetter, et al.
Pageof 190